PT  - JOURNAL ARTICLE
AU  - Enticott, Joanne
AU  - Gill, Jaskirath
AU  - Bacon, Simon
AU  - Lavoie, Kim
AU  - Epstein, Dan
AU  - Dawadi, Shrinkhala
AU  - Teede, Helena
AU  - Boyle, Jacqueline
TI  - Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications in Australia
AID  - 10.1101/2021.09.12.21263158
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.12.21263158
4099  - http://medrxiv.org/content/early/2021/09/15/2021.09.12.21263158.short
4100  - http://medrxiv.org/content/early/2021/09/15/2021.09.12.21263158.full
AB  - Objective To examine SARS-CoV-2 vaccine confidence, attitudes and intentions in Australian adults.Methods Nationwide survey in February-March 2021 of adults representative across sex, age and location. Vaccine uptake and a range of putative drivers of uptake, including vaccine confidence, socioeconomic status, and sources of trust, were examined using logistic and Bayesian regressions for vaccines generally and for SARS-CoV-2 vaccines.Results Overall 1,166 surveys were collected from participants aged 18-90 years (mean 52, SD of 19). Seventy-eight percent reported being likely to receive a vaccine against COVID-19. Higher SARS-CoV-2 vaccine intentions were associated with: increasing age (OR: 1.04 95%CI [1.03-1.044]), being male (OR: 1.37, 95% CI [1.08 – 1.72]), residing in the least disadvantaged area quintile (OR: 2.27 95%CI [1.53 – 3.37]) and a self-perceived high risk of getting COVID-19 (OR: 1.52 95% CI [1.08 – 2.14]). However, 72% of participants did not believe that they were at a high risk of getting COVID-19. Findings regarding vaccines in general were similar except there were no sex differences. For both the SARS-CoV-2 vaccine and vaccines in general, there were no differences in intentions to vaccinate as a function of education level, perceived income level, and rurality. Knowing that the vaccine is safe and effective, and that getting vaccinated will protect others, trusting the company that made it and getting vaccination recommended by a doctor were reported to influence a large proportion of the study cohort to uptake the SARS-CoV-2 vaccine. Seventy-eight percent reported the intent to continue engaging in virus-protecting behaviours (mask wearing, social distancing etc.) post-vaccine.Conclusions Seventy-eight percent of Australians are likely to receive a SARS-CoV-2 vaccine. Key influencing factors identified in this study (e.g. knowing that the vaccine is safe and effective, getting a doctor’s recommendation to get vaccinated) can be used to inform public health messaging to enhance vaccination rates.Strengths and limitations of this studyThis research captured a large, representative sample of the adult Australian population across age, sex, location, and socioeconomic status.We have self-reported Australian uptake intentions and attitudes on general vaccines and COVID-19 vaccine, and intent to continue engaging in virus-protecting behaviours (mask wearing, social distancing etc.) post SARS-CoV-2 vaccine.We examine a range of drivers and factors that may influence intent to get the SARS-CoV-2 vaccine uptake, including vaccine confidence, demographics and socioeconomic status.The survey is based on established behavioural theories, and is the Australian arm of the international iCARE survey which to date has collected global comparative information from over 90,000 respondents in 140 countries.Our survey was only available in English, which may have led to an underrepresentation of ethnic groups, and participation was voluntary, so our sample may be prone to selection bias from those with more interest or engagement in COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors and their institutions did not receive payment or services from a third party for any aspect of this submitted work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This project was approved by the Monash University Human Research Ethics Committee (#ID: 24449).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be made available to approved researchers by contacting the corresponding author.